Compare GSK plc (GSK) vs Annaly Capital Management, Inc. (NLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Annaly Capital Management, Inc. — how do they compare? GSK plc trades at $52.67 (market cap $101.34B), while Annaly Capital Management, Inc. trades at $23.43 (market cap $16.97B). The key difference: GSK plc is far larger — about 6× Annaly Capital Management, Inc.'s market cap, and Annaly Capital Management, Inc. pays the higher dividend (12.95%). Which is the better fit depends on your goals.
| GSK | NLY | |
|---|---|---|
Market Cap | $101.34B | $16.97B |
Sector | Health | Financials |
52-Week High | $61.18 | $24.40 |
52-Week Low | $36.20 | $19.69 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | 12.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
NLY trades at $23.01, up 2.13% today, with a bullish technical signal from moving averages and a consensus analyst price target of $24.40. The stock shows strong profitability with a 91.17% net income margin and 15.61% ROE, supported by recent earnings beats. A dividend yield of approximately 13% attracts income investors, though cash flow volatility and high leverage pose risks. Recent news highlights sensitivity to interest rate changes and earnings growth potential.
Outlook: NLY offers high dividend income and earnings momentum, but investors face interest rate sensitivity and balance sheet leverage. Upside depends on stable Fed policy and mortgage spread management, while downside risks include economic shifts affecting refinancing demand and funding costs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Annaly Capital Management, Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →
